Valuation and Modelling
Bathiya develops defensible valuation frameworks and scenario-driven financial models.We deliver numbers that withstand investor, auditor and regulatory scrutiny
About Valuation and Modelling
Defensible numbers. Strategic insight.
We undertake valuation assignments across acquisition pricing, regulatory requirements, financial reporting, dispute contexts and compensation structuring. Our models incorporate scenario analysis, sensitivity matrices and capital sustainability assessments to ensure outputs withstand scrutiny from auditors, regulators, investors and lenders.
- Equity, convertible and ESOP valuations
- Acquisition pricing, swap ratios and fairness opinions
- Revenue, margin and leverage scenario analysis
- PPA, impairment and restructuring models
Our speciality
Need for an integrated valuation and modelling framework
Strategic Valuation
- We deliver acquisition pricing, regulatory and dispute valuations aligned to commercial objectives.
Instrument & Equity Modelling
- We value equity shares, convertible instruments, ESOPs and intangible assets with analytical precision.
Scenario & Sensitivity Analysis
- We model revenue variability, margin compression, leverage adjustments and exit multiple shifts to assess downside resilience.
Compliance & Reporting Precision
- We structure purchase price allocations, impairment testing and restructuring models aligned with Ind AS and IFRS standards.
Our proud moments
We strive to be the best
![[object Object]](/images/text-icon.svg){kind=icon}
Advised India’s largest M&A transactions in the Pharmaceuticals
Advised India’s first Phase-II investigation conducted by the Competition Commission of India
Advised India's largest Japan outbound and inbound-exit
40+ Years
of holistic partner experience
350+ Years
Third-party M&A transactions
100+ Years
Cross-border M&A transactions
250+ Years
Independent M&A valuation engagement
100+ Years
Third-party in(out) licensing & JV M&A transactions
Our Work
We work across
industries
Finance
Sports
Media & Entertainment
Pharma M&A
PharM&A blends M&A expertise with pharma domain knowledge for holistic solutions. Bathiya's decades advising landmark pharma/healthcare deals built this niche.
Insights
We strive to deliver value
Core team
Meet our leaders
Transaction head
Anand Bathiya
B. Com. (Hons) | F.C.A. | CS | LL.B | DISA | Partner
M&A head
Kedar Kingi
MBA in Finance